+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of Hodgkins disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone and adriamycin, bleomycin, vinblastine, and dacarbazine courses without radiotherapy



Treatment of Hodgkins disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone and adriamycin, bleomycin, vinblastine, and dacarbazine courses without radiotherapy



Medical & Pediatric Oncology 29(1): 23-27



Since the introduction of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy, children with Hodgkin's disease (HD) have been treated with chemotherapy alone. The occurrence of side effects related to irradiation (especially secondary solid tumors) is less likely to occur. Alkylating agents in the MOPP chemotherapy combinations are, however, known for their late effects, i.e., gonadal dysfunction and secondary malignancies. Combination with non-alkylating and non-cross-resistant drugs (as in the adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) combination) may give superior treatment results and possibly a decrease in the occurrence of side effects. From 1988 to 1993 all children presenting with HD were treated with alternating MOPP and ABVD courses (3 x MOPP, 3x ABVD). Twenty-one children (7 females, 14 males), ages 5-18 years (median 14 years) were included; their clinical stages were I, 7 patients; II, 8 patients;III, 5 patients; IV, 1 patient. Their pathology revealed 2 lymphocytic predominance, 17 nodular sclerosis, 1 mixed cellularity. In 1 patient only cytology was done and thus histopathologic subclassification was not possible. Two children have relapsed; disease-free survival is 90%. Analysis of toxicity revealed no decrease in cardiac function by ultrasound examination and no pulmonary effects noted by carbon monoxide diffusion. In 1 of the 10 children tested, mild hypogonadism was noted. No secondary tumors occurred. From this small population of children with HD we conclude that treatment with MOPP/ABVD for 6 cycles without radiotherapy may be adequate. The occurrence of gonadal dysfunction may be less frequent than with 6 cycles of MOPP. However, more patients and further follow-up are needed.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034063707

Download citation: RISBibTeXText


Related references

Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy. Medical and Pediatric Oncology 29(1): 23-27, 1997

Treatment of mechlorethamine vincristine procarbazine prednisone resistant hodgkins disease with adriamycin bleomycin vinblastine and dacarbazine. European Journal of Cancer & Clinical Oncology 18(9): 803-806, 1982

Mechlorethamine vincristine procarbazine prednisone vs. mechlorethamine vincristine procarbazine prednisone alternating with streptozotocin 1 2 chloroethyl 3 cyclohexyl 1 nitroso urea adriamycin and bleomycin for advanced hodgkins disease. Proceedings of the American Association for Cancer Research & American Society of Clinical Oncology 22: 159, 1981

Gonadal toxicity after combination chemotherapy for hodgkins disease comparative results of mopp mechlorethamine vincristine procarbazine and prednisone vs. adriamycin bleomycin vinblastine and dacarbazine. European Journal of Cancer and Clinical Oncology 21(5): 601-606, 1985

Comparison of adriamycin containing chemo therapy mechlorethamine vincristine procarbazine prednisone and adriamycin with mechlorethamine vincristine procarbazine prednisone and bleomycin in the management of advanced hodgkins disease a southwest oncology group study. Cancer 51(8): 1339-1347, 1983

Doxorubicin bleomycin vinblastine and dacarbazine salvage of mechlorethamine vincristine prednisone and procarbazine resistant advanced hodgkins disease. Cancer Treatment Reports 68(7-8): 947-952, 1984

Adriamycin bleomycin vinblastine di methyltriazeno imidazolecarboxamide treatment of mechlorethamine vincristine procarbazine prednisone failures in hodgkins disease a reexamination of goals of salvage therapy. Cancer Treatment Reports 62(3): 363-368, 1978

Salvage chemo therapy with adriamycin bleomycin vinblastine daunomycin in mechlorethamine vincristine procarbazine prednisone resistant hodgkins disease. Proceedings of the American Association for Cancer Research & American Society of Clinical Oncology 22: 522, 1981

Therapeutic and toxicologic effects of mechlorethamine vincristine procarbazine prednisone vs. adriamycin bleomycin vinblastine daunomycin when combined with radio therapy in hodgkins disease. Proceedings of the American Association for Cancer Research & American Society of Clinical Oncology 22: 522, 1981

Cyclic delivery of mechlorethamine vincristine procarbazine prednisone and doxorubicin bleomycin vinblastine dacarbazine combinations in stage iv hodgkins disease rationale background studies and recent results. Cancer Treatment Reports 66(4): 881-888, 1982

Combined modality therapy of advanced recurrent hodgkins disease a randomized trial testing bcg methanol extraction residue immuno therapy and chemo therapy of 1 2 chloroethyl 3 cyclohexyl 1 nitroso urea vinblastine procarbazine prednisone and bleomycin adriamycin vincristine streptozotocin and alternating sequences of 1 2 chloroethyl 3 cyclohexyl 1 nitroso urea vinblastine procarbazine prednisone and bleomycin adriamycin vincristine streptozotocin. Cancer Treatment Reports 66(4): 1065, 1982

Combined chemo therapy mechlorethamine vincristine procarbazine prednisone or adriamycin bleomycin vinblastine di methyltriazeno imidazolecarboxamide radio therapy approach in advanced hodgkins disease. Cancer Treatment Reports 61(5): 769-778, 1977

Alternating Combination Chemotherapy C-Mopp (Cyclophosphamide, Vincristine, Procarbazine, Prednisone) and Abvd (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) in Clinical Stage Ii-Iv Hodgkin's Disease: a Multicenter Phase Ii Study (Jcog 8905). Japanese Journal of Clinical Oncology 30(3): 146-152, 2000

Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease. Cancer Treatment Reports 68(7-8): 947-951, 1984

Noncross resistant regimens nitrogen mustard vincristine procarbazine prednisone and adriamycin bleomycin vinblastine dactinomycin vs. nitrogen mustard vincristine procarbazine prednisone alone in stage iv hodgkins disease. Proceedings of the American Association for Cancer Research & American Society of Clinical Oncology 21: 470, 1980